The site is also integrated into a cloud based CRM system. The website has been designed to elevate the company’s brand position, with design elements including technical illustrations and product pathway maps to depict Horizon’s capabilities and product offerings.
Cambridge-based biotechnology company Horizon chose to work with KISS and Zyme based on their combined life science sector expertise and creative design capability. Horizon had an existing relationship with Zyme and when the opportunity to redevelop Horizon’s website arose, Lorna Cuddon, Managing Director at Zyme, turned to its design and digital partner KISS to manage the project, and design and build the new site, injecting creativity and ingenuity. The two agencies worked closely together throughout the project.
Horizon is one of the fastest growing biotechnology companies in Europe and combines a long scientific heritage in translational research with a world-leading gene-editing platform based upon homologous recombination. The company is a trusted supplier of genetically-defined cell lines, reporter gene assay kits, and genomic referencestandards and contract research services to organisations engaged in bio-pharmaceutical process optimisation, drug discovery & development, and clinical diagnostic development.
Chris Claxton, Marketing Director at Horizon said: “The whole process from planning to design, build and implementation has been a pleasure. The Zyme and KISS teams work very well together and their combined experience, knowledge and creativity have delivered a world class site that matches Horizon’s ambitions.”
Lorna Cuddon, Managing Director of Zyme, said: “The new website brings to life Horizon’s scientific heritage, developing its brand position within the market. KISS works across industry sectors, at the cutting edge of design/digital and the team was able to apply its experience and expertise to this project, to build a website that stands out above the competition.”
Simon Fryer, CEO of KISS, said: “By applying our approach to make things as simple and effective as they can be, we have been able to deliver on a complex requirement whilst elevating the online identity of Horizon Discovery. We are very pleased with the completed site and have enjoyed working with the marketing and technical teams at Horizon and also Zyme, who have brought their unparalleled life science experience to this project.”
About Horizon Discovery www.horizondiscovery.com
Horizon Discovery Limited (Horizon) is a leading provider of research tools to support translational genomics research and the development of personalized medicines. The Company’s proprietary technology, GENESIS™, is the world’s most precise genome editing technology. Using GENESIS™, Horizon is able to alter any endogenous gene sequence of a human or mammalian cell-line quickly, reliably and without introducing unwanted and confounding genotypes and/or phenotypes.
Horizon has harnessed GENESIS™ to create over 450 X-MAN™ cell lines, the world’s first source of genetically-defined and patient-relevant human cell lines, accurately modeling the disease causing mutations found in cancer patients. These ‘patients-in-a-test-tube’ are being used by academic and industry leaders to identify the effect of individual genetic mutations on drug activity, patient responsiveness, and resistance, leading to the successful prediction of which patient sub-groups will respond to currently-available and future drug treatments. This enables the design of shorter, more focused, and less expensive clinical trials, ultimately providing the tools to identify the ‘right drugs’ for the ‘right patients’ based upon the unique genetic mutations that define their disease.
In addition to the X-MAN™ cell lines, Horizon provides GENESIS™ and X-MAN™ derived products and services, with industrial application in: bio-pharmaceutical process optimization; clinical diagnostic development; drug discovery & development; and the provision of reference standards for genomic-based clinical research platforms.
About Zyme Communications www.zymecommunications.com
Zyme Communications provides PR and marketing services for the life science sector, supporting companies to raise their profile, build corporate value, and generate interest from commercial leads, investors and partners. Based in Cambridge, UK, and with partners in Europe and the US, Zyme is focused on providing real value from objective-led communications. Zyme has an experienced senior team, who are specialists in life science PR and marketing and is ideally positioned to support clients to reach their target audiences, from bench scientist to decision-maker, and small biotech to international pharma.
About KISS Communications www.kisscom.co.uk
KISS Communications is the integrated agency built on the philosophy of keeping things simple. Our experienced team energises brands that aspire to be number one in their category, gain distribution and increase sales around the world.
We provide strategy, advertising, design, branding, digital and exhibition services. The KISS guiding principles are to have a lack of unnecessary complexity in everything we do whilst delivering maximum effect with minimum means.
The agency has won an impressive number of blue chip clients, including Anglian Water, Bokomo Foods UK, PlastiKote, Booking.com, Johnson Matthey, Bosch, Valspar and successful SMEs including One Nucleus, Balancing Blooms, Geomerics, Horizon Discovery, IMRG, Real-Status, Intergence, and Cambridge Past, Present & Future.
Join our Art of Simplicity Campaign on Pinterest and Twitter.
*******
For further information, please contact:
Lorna Cuddon
Zyme Communications
T: 01223 968 920
lorna.cuddon@zymecommunications.com
Laura Brown
KISS Communications
T: 01223 911 123 or 0208 12345 75
_____________________________________________________